Join waitlist
Procter & Gamble Health Ltd.
₹5,218.00
+516.00 (10.97%)
1Y
Sector:
Healthcare
Industry:
Pharmaceuticals & Drugs
Healthcare
Pharmaceuticals & Drugs
NSE
BSE
The current prices were last updated on 17 Apr
Price
1D
-0.42%
1W
-0.42%
1M
1.29%
3M
-2.34%
6M
0.21%
1Y
10.97%
3Y
22.34%
5Y
21.35%
Max
22.63%
1W
-0.42%
1M
1.29%
1Y
10.97%
3Y
22.34%
5Y
21.35%
Max
22.63%
Procter&Gamble Healt Overview
4,636.55
52W Low
5,850.00
52W High
P/E
41.71
Sector P/E
30.83
P/B
15.83
Sector P/B
3.10
Adj EPS
121.07
BVPS
319.10
OPM(%)
26.58
NPM(%)
15.96
ROE(%)
31.58
ROCE(%)
42.52
D/E
0
Div. Yld(%)
5.15
Procter&Gamble Healt Historical Returns
1 Day
-0.42 %
1 Week
-0.42 %
1 Month
1.29 %
3 Month
-2.34 %
6 Month
0.21 %
1 Year
10.97 %
3 Year
22.34 %
5 Year
21.35 %
Max
22.63 %
Procter&Gamble Healt Financials
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
*All values are in Rs. Cr
Consolidated
Name | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Net Sales | 309.77 | 313.41 | 283.88 | 252.48 |
| Sales | 309.77 | 313.41 | 283.88 | 252.48 |
| Less: Excise Duty | 0 | 0 | 0 | 0 |
| Operating Expenses | 186.34 | 199.37 | 235.63 | 185.04 |
| Raw Material Cost | 61.60 | 48.17 | 67.42 | 64.66 |
| Power cost | 0 | 0 | 0 | 0 |
| Employee Cost | 47.05 | 46.22 | 48.63 | 48.46 |
| Other Expenses | 77.69 | 104.98 | 119.58 | 71.92 |
| Increase / Decrease In Stocks | 0.85 | 19.72 | -6.76 | -1.93 |
| Purchase of Finished Goods | 13.28 | 20.16 | 18.51 | 11.13 |
| Manufacturing Expenses | 63.56 | 65.10 | 107.83 | 62.72 |
| General Administration Expenses | 0 | 0 | 0 | 0 |
| Selling & Distribution Expenses | 0 | 0 | 0 | 0 |
| Misc Expenses | 0 | 0 | 0 | 0 |
| Loss Foreign Exchange | 0 | 0 | 0 | 0 |
| Loss Foreign Exchange Loan | 0 | 0 | 0 | 0 |
| Expenses Capitalised | 0 | 0 | 0 | 0 |
| Operating Profit (Excluding OI) | 123.43 | 114.04 | 48.25 | 67.44 |
| Other Income | 3.96 | 3.28 | 22.32 | 2.27 |
| Other Income Normal | 3.96 | 3.28 | 2.13 | 2.27 |
| Exceptional Items | 0 | 0 | 20.19 | 0 |
| Operating Profit Margin | 39.85 | 36.39 | 17.00 | 26.71 |
| EBIDTA | 127.39 | 117.32 | 70.57 | 69.71 |
| Less: Interest | 0.15 | 0.15 | 0.20 | 0.15 |
| Less: Depreciation | 5.55 | 5.77 | 7.16 | 6.84 |
| Profit Before Tax | 121.69 | 111.40 | 22.83 | 62.72 |
| Less: Tax | 30.79 | 29.07 | 6.05 | 16.16 |
| Net Profit | 90.90 | 82.33 | 16.78 | 46.56 |
| Earnings Per Share | 54.76 | 49.60 | 10.11 | 28.00 |
| Net Profit Margin | 29.34 | 26.27 | 5.91 | 18.44 |
Name | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|
| Net Sales | 1,151.26 | 1,229.62 | 1,114.41 | 1,008.73 |
| Sales | 1,259.24 | 1,328.24 | 1,177.84 | 1,008.73 |
| Less: Excise Duty | - | - | - | - |
| Operating Expenses | 845.26 | 904.94 | 846.73 | 762.71 |
| Raw Material Cost | 329.69 | 358.99 | 344.55 | 310.39 |
| Power cost | 8.50 | 12.88 | 14.70 | 12.97 |
| Employee Cost | 215.16 | 206.17 | 167.56 | 153.66 |
| Other Expenses | 291.04 | 324.05 | 324.67 | 283.96 |
| Other Manufacturing Expenses | 113.33 | 126.07 | 132.01 | 125.61 |
| Selling and administrative expenses | 99.67 | 87.16 | 60.88 | 51.79 |
| Selling Expenses | 52.65 | 74.49 | 109.45 | 87.41 |
| Miscellaneous Expenses | 25.39 | 36.33 | 22.33 | 19.15 |
| Less: Expenses Capitalised | - | - | - | - |
| Operating Profit (Excluding OI) | 306.00 | 324.68 | 267.68 | 246.02 |
| Other Income | -4.56 | 18.39 | 13.19 | 18.10 |
| Other Income Normal | 15.63 | 18.39 | 13.19 | 18.10 |
| Exceptional Items | -20.19 | - | - | - |
| Operating Profit Margin | 26.58 | 26.40 | 24.02 | 24.39 |
| EBIDTA | 301.44 | 343.07 | 280.87 | 264.12 |
| Interest | 0.72 | 0.77 | 0.42 | 0.80 |
| Depreciation | 27.40 | 28.10 | 27.08 | 30.04 |
| Profit Before Tax | 273.32 | 314.20 | 253.37 | 233.28 |
| Tax | 72.34 | 84.73 | 60.85 | 56.48 |
| Profit After Tax | 200.98 | 229.47 | 192.52 | 176.80 |
| Extra Items | - | - | - | - |
| Minority Interest | - | - | - | - |
| Share Associate | - | - | - | - |
| Other Consolidated Items | - | - | - | - |
| Net Profit | 200.98 | 229.47 | 192.52 | 176.80 |
| Equity Dividend % | 2,600.00 | 950.00 | 525.00 | 1,300.00 |
| Earnings Per Share | 121.07 | 138.23 | 115.98 | 106.51 |
| Net Profit Margin | 15.96 | 17.28 | 16.35 | 17.53 |
Name | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|
| Equity And Liabilities | 2,004.09 | 2,232.97 | 1,937.85 | 1,977.81 |
| Shareholder's Funds | 538.24 | 750.89 | 616.49 | 703.71 |
| Share Capital | 16.60 | 16.60 | 16.60 | 16.60 |
| Share Warrants & Outstandings | 8.53 | 7.84 | 7.28 | 3.87 |
| Total Reserves | 513.11 | 726.45 | 592.61 | 683.24 |
| Reserve excluding Revaluation Reserve | 513.11 | 726.45 | 592.61 | 683.24 |
| Revaluation reserve | - | - | - | - |
| Non-Current Liabilities | 840.55 | 803.00 | 713.63 | 723.42 |
| Secured Loans | - | - | - | - |
| Unsecured Loans | - | - | - | - |
| Deferred Tax Assets / Liabilities | -33.69 | -25.32 | -19.65 | -19.91 |
| Other Long Term Liabilities | 874.24 | 828.32 | 733.28 | 743.33 |
| Rest of the Other Long Term Liabilities | 7.57 | 9.53 | 0.60 | 3.43 |
| Long Term Trade Payables | - | - | - | - |
| Long Term Provisions | 866.67 | 818.79 | 732.68 | 739.90 |
| Current Liabilities | 625.30 | 679.08 | 607.73 | 550.68 |
| Trade Payables | 167.00 | 237.04 | 172.08 | 178.91 |
| Other Current Liabilities | 38.22 | 42.49 | 42.32 | 36.64 |
| Short Term Borrowings | - | - | - | - |
| Short Term Provisions | 420.08 | 399.55 | 393.33 | 335.13 |
| Assets | 2,004.09 | 2,232.97 | 1,937.85 | 1,977.81 |
| Non-Current Assets | 1,073.48 | 1,061.69 | 953.98 | 938.96 |
| Net Block | 126.60 | 141.72 | 109.06 | 100.96 |
| Gross Block | 223.32 | 263.07 | 241.11 | 214.90 |
| Less: Accumulated Depreciation | 96.72 | 121.35 | 131.32 | 113.94 |
| Less: Impairment of Assets | - | - | 0.73 | - |
| Lease Adjustment | - | - | - | - |
| Capital Work in Progress | 5.89 | 32.49 | 40.60 | 39.15 |
| Other Non Current Assets | 939.09 | 885.23 | 801.72 | 795.90 |
| Long Term Investments | - | - | - | - |
| Long Term Loans & Advances | 939.09 | 885.23 | 801.72 | 795.90 |
| Other Non Current Assets | - | - | - | - |
| Current Assets | 930.61 | 1,171.28 | 983.87 | 1,038.85 |
| Inventories | 109.11 | 134.94 | 115.21 | 118.37 |
| Account Receivables | 85.33 | 115.71 | 83.44 | 59.81 |
| Cash and Bank | 244.36 | 440.22 | 324.53 | 468.91 |
| Other Current Assets | 491.81 | 480.41 | 460.69 | 391.76 |
| Current Investments | - | - | - | - |
| Other Current Assets | 24.17 | 13.73 | 7.95 | 6.36 |
| Short Term Loans and Advances | 467.64 | 466.68 | 452.74 | 385.40 |
| Book Value | 319.10 | 447.62 | 366.99 | 421.59 |
Name | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|
| Cash from Operating Activity | 228.29 | 236.01 | 169.52 | 247.26 |
| Profit Before Tax | 273.32 | 314.20 | 253.37 | 233.28 |
| Adjustments | 52.27 | 41.49 | 27.31 | 40.89 |
| OCF Before Working Capital | 325.59 | 355.69 | 280.68 | 274.17 |
| Working Capital Changes | -12.12 | -30.02 | -47.30 | 41.22 |
| Taxes Paid | -85.18 | -89.66 | -63.86 | -68.13 |
| Cash from Investing Activity | -6.87 | -21.50 | -25.54 | -32.27 |
| Net Fixed Assets Purchased | - | - | - | - |
| Fixed Assets Purchased | - | - | - | - |
| Fixed Assets Sold | - | - | - | - |
| Investment Purchased | 273.32 | 314.20 | 253.37 | 233.28 |
| Investment Sold | - | - | - | - |
| Dividends Recieved | - | - | - | - |
| Interest Recieved | - | - | - | - |
| Subsidiary Investments | - | - | - | - |
| Cash from Financing Activity | -418.11 | -98.47 | -288.63 | -386.63 |
| Proceeds From Shares | - | - | - | - |
| Net Long Term Borrowings | - | - | - | - |
| Proceeds From Borrowings | - | - | - | - |
| Repayment From Borrowings | - | - | - | - |
| Interest Paid | - | - | - | - |
| Dividend Paid | - | - | - | - |
| Net Cash Flow | -196.69 | 116.04 | -144.65 | -171.64 |
| Opening Cash & Cash Equivalents | 435.42 | 319.40 | 464.05 | 635.69 |
| Effect of FX | - | - | - | - |
| Closing Cash & Cash Equivalents | - | - | - | - |
| Free Cash Flow (est) | - | - | - | - |
| Net Capex (est) | - | - | - | - |
*All values are in Rs. Cr
Procter&Gamble Healt Financial Ratios
Valuations
Profitability
Efficiency
Leverage
Operational
Name | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
| Book Value Per Share | 319.10 | 447.62 | 366.99 | 421.59 | 544.82 |
| P/B | 15.83 | 11.73 | 11.41 | 13.27 | 7.47 |
| P/E | 41.71 | 37.97 | 36.10 | 52.52 | 26.57 |
| EV/EBIDTA | 25.30 | 24.12 | 23.59 | 33.38 | 15.91 |
| Market Cap/Sales | 7.28 | 7.09 | 6.24 | 9.21 | 4.98 |
Name | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
| Net Profit Margin (%) | 15.96 | 17.28 | 16.35 | 17.53 | 18.74 |
| Gross Margin (%) | 24.30 | 24.44 | 22.73 | 24.39 | 23.18 |
| Operating Profit Margin (%) | 26.58 | 26.40 | 24.02 | 24.39 | - |
Name | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
| ROE (%) | 31.58 | 33.94 | 29.41 | 22.04 | 20.79 |
| ROCE (%) | 42.52 | 46.07 | 38.45 | 29.08 | 29.01 |
| ROA (%) | 9.49 | 11.00 | 9.83 | 8.65 | 10.82 |
| Capital Adequacy Ratio (%) | - | - | - | - | - |
Name | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
| D/E Ratio | 0 | 0 | 0 | 0 | 0 |
| Interest Coverage Ratio | 380.61 | 409.05 | 604.26 | 292.60 | - |
| Current Ratio | 1.49 | 1.72 | 1.62 | 1.89 | 2.35 |
Name | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
| Cash Conversion Cycle (Days) | -158.56 | -144.61 | -130.12 | -103.36 | -35.95 |
| Days Receivables (Days) | 29.14 | 27.36 | 22.20 | 28.06 | 21.73 |
| Inventory Days (Days) | 35.37 | 34.37 | 36.19 | 45.68 | 33.31 |
| Days Payables (Days) | 223.07 | 206.35 | 188.51 | 177.09 | 90.99 |
| Free Cash Flow to Share | 117.19 | 111.49 | 80.95 | 117.76 | 153.33 |
| Inventory Turnover Ratio | 10.32 | 10.62 | 10.09 | 7.99 | 10.96 |
| Asset Turnover Ratio | 0.59 | 0.64 | 0.60 | 0.49 | 0.58 |
Procter&Gamble Healt FAQs
What is the current share price of Procter&Gamble Healt?
As of 17 Apr, the current share price of Procter&Gamble Healt is ₹5218 per share.
What is the P/E ratio of Procter&Gamble Healt?
The Price-to-Earnings (P/E) ratio of Procter&Gamble Healt is 41.71. It is calculated based on its most recent quarterly earnings. The P/E ratio compares the company's current share price to its quarterly earnings per share (EPS), helping investors evaluate its market value relative to its earnings.
What is the EPS for Procter&Gamble Healt?
As reported in the latest quarterly financial statements, the Earnings Per Share (EPS) for Procter&Gamble Healt is ₹121.07. EPS is calculated by dividing the company's net income for the quarter by the number of outstanding shares, indicating how much profit is allocated to each share of stock during that period.
What is the ROE and ROCE of Procter&Gamble Healt?
As per latest financial reports, Procter&Gamble Healt has a Return on Equity (ROE) of 31.58% and a Return on Capital Employed (ROCE) of 42.52%. ROE measures the profitability relative to shareholders' equity, while ROCE assesses how efficiently the company utilizes its capital to generate profits.
What is the debt-to-equity ratio of Procter&Gamble Healt?
The debt-to-equity ratio of Procter&Gamble Healt is 0 according to its latest financial report. This ratio compares the company's total liabilities to its shareholder equity and is used to evaluate its financial leverage and risk level.
Excited to Invest?
Join our waitlist now and get early access to our platform!
Similar stocks
See more
Excited to Invest?
Join our waitlist now and get early access to our platform!
TRADE CONFIDENTLY
Address - 2nd Floor HSR Layout, 17th cross road Bengaluru – 560103
Contact Us:
+91-8197368610
Connect with us
Copyright © 2024 MintCap Enterprises Private Limited
Mintcap Brokers Private Limited
SEBI Registration : INZ000322732 | BSE Membership No: 6903
NSE Membership No : 90430